期刊文献+

载吉西他滨磁性含铁纳米微球治疗胰腺癌细胞的体外研究 被引量:1

In vitro study on gemcitabine carryingg iron-containing magnetic nanoparticles in treating pancreatic carcinoma cells
下载PDF
导出
摘要 目的制备载吉西他滨磁纳米微球(Gem-CCMN),考察其协同恒定外磁场下对人胰腺癌细胞CAPAN-2的体外杀伤效应。方法采用化学共价耦联法制备Gem-CCMN,扫描电子纤维镜(SEM)观察纳米粒形态,紫外分光光度计法测定载药量及包封率,体外考察Gem-CCMN在拟溶菌酶存在的不同pH值下药物累积释放率,MTT法检测协同恒定外磁场下Gem-CCMN对CAPAN-2体外增殖的抑制效应,流式细胞术(FCS)检测细胞凋亡。结果 Gem-CCMN呈球形,平均粒径约为50nm,载药量为15%,包封率为45%,pH=7时48h累积释放量仅25%,pH=2时药物累计释放率可达84%;Gem-CCMN协同外磁场时可增强对肿瘤细胞增殖的抑制作用,诱导细胞凋亡和坏死。结论 Gem-CCMN联合外磁场可有效抑制CAPAN-2细胞的生长。 Objective To prepare the gemcitabine carrying magnetic nanoparticles(Gem-CCMN)and to investigate their in vitro killing effects on pancreatic carcinoma cell line CAPAN-2in collaboration of the constant external magnetic fields.Methods Gem-CCMN was prepared by the chemical covalent linkage coupling procedure.Its morphology was observed by scanning electron microscope(SEM).The drug loading amount and encapsulating ratio were determined by the ultraviolet spectrophotometry.The accumulating release rate of Gem-CCMN under different pH values in the existence of lysozyme was investigated in vitro.The in vitro growth inhibiting effect of Gem-CCMN on CAPAN-2under the collaborative constant external magnetic field was detected by the MTT assay.The apoptosis of CAPAN-2was detected by the flow cytometry.Results Gem-CCMN were spherical with average diameter of 50 nm,the drug loading amount was 15% and the encapsulating ratio was 45%.The 48 hcumulative drug release amount at pH=7was only 25%,but which at pH=7could reach 84%;Gem-CCMN collaborated with external magnetic fields could enhance the killing effect on CAPAN-2,also induced the cellular apoptosis and necrosis.Conclusion Gem-CCMN combined with external magnetic fields could effectively inhibit the growth of CAPAN-2in vitro.
出处 《检验医学与临床》 CAS 2015年第14期1984-1986,共3页 Laboratory Medicine and Clinic
基金 国家重大专项课题(2012ZX10002~016) 中山大学临床研究5010项目(2010009)
关键词 吉西他滨 纳米 胰腺癌 CAPAN-2 杀伤 gemcitabine nanoparticles pancreatic carcinoma CAPAN-2 killing
  • 相关文献

参考文献10

  • 1Moore MJ, Hamm J, Dancey J, et al. Comparison of gem- citabine versus the matrix metallop-roteinase inhibitor BAY-12-9566 in patients with advanced or metastatic ade- nocarcinoma of the pancreas.a phase HI trial of the Na- tional Cancer Inatitute of Canada Clinical Trials Group [J]. J Clin 0ncol,2003,21(17) :3296-3300.
  • 2Reddy LH. Drug delivery to tumours: recent strategies [J]. J Pharm acol,2005,57(10) :123-124.
  • 3Widder KJ, Morris RM, Poore G, et al. Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin [J]. Proc Natl Acad Sci,1981,78(20) :579-581.
  • 4Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J]. Adv Drug Deliv Rev,2003,55(3).329 347.
  • 5Sunil AA, Nadagouda NM, Tejraj MA. Recent advances on chitosan 2 based micro 2 and nanoparticles in drug de- livery[J]. J Control Rel, 2004,100 ( 1 ) 5-28.
  • 6荣向辉.吕霁,吕盈.顺磁性紫杉醇纳米微粒对中枢神经系统肿瘤磁靶向药物化疗的实验分析[J].医学信息,2013,26(6):126130.
  • 7Diaz-Rubio E. New chemotherapeutic advances in pancre- atic, coloreetal, and gastric cancers[J]. Oncologist, 2004,9 (10).282-294.
  • 8Yalen S, Erkan M, tinsoy G, et al. Effect of gemeitabine and retinoic acid loaded PAMAM dendrimer coated mag netic nanoparticles on pancreatic cancer and stellate cell lines[J]. Biomed Pharmacother,2014,68(6) :737-743.
  • 9Wang Y,Zhou Y,Jia G,et al. Shikonin suppresses tumor growth and synergizes with gemeitabine in a pancreatic cancer xenograft model: involvement of NF-B signaling pathway[J]. Biomed Pharmacother,2014,88(3) :322 333.
  • 10Smith JA, Brown J, Martin MC, et al. An in vitro study of the inhibitory aetivity o{ gemeitahine andplatinum agents in human endometrial carcinoma cell lines[J]. Gynecol Oncol,2004,92(10) :314-319.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部